Takeshi Nakano Selected Research

Pulmonary Embolism

1/2009	Percutaneous cardiopulmonary support for the treatment of acute pulmonary embolism: summarized review of the literature in Japan including our own experience.
8/2005	Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer.
3/2005	Effectiveness and safety of the thrombolytic therapy for acute pulmonary thromboembolism: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research.
3/2005	[Therapy of acute pulmonary thromboembolism from the physician's standpoint].
2/2005	Triggers of acute pulmonary thromboembolism developed in hospital, with focusing on toilet activities as triggering acts.
1/2005	Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.
9/2004	Inferior vena cava filter is a new additional therapeutic option to reduce mortality from acute pulmonary embolism.
8/2004	High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
7/2003	Association between antithrombotic treatments and prognosis of patients with acute pulmonary thromboembolism in Japan.
6/2003	Recent developments in diagnostic imaging techniques and management for acute pulmonary embolism: multicenter registry by the Japanese Society of Pulmonary Embolism Research.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Nakano Research Topics

Disease

35	Hepatocellular Carcinoma (Hepatoma) 08/2006 - 01/2002
28	Neoplasms (Cancer) 01/2012 - 02/2002
11	Pulmonary Embolism 01/2009 - 12/2002
7	Fibrosis (Cirrhosis) 03/2008 - 03/2002
6	Myocardial Infarction 01/2008 - 07/2002
6	Infections 12/2005 - 08/2002
6	Venous Thrombosis (Deep-Vein Thrombosis) 08/2005 - 12/2002
6	Liver Cirrhosis (Hepatic Cirrhosis) 03/2005 - 07/2002
5	Chronic Hepatitis C 12/2005 - 09/2002
5	Heart Failure 10/2005 - 04/2003
5	Tachycardia (Tachyarrhythmias) 04/2005 - 02/2002
4	Hepatitis 11/2005 - 09/2002
4	Adenocarcinoma 10/2005 - 05/2002
4	Hemorrhage 11/2003 - 07/2002
3	Thrombosis (Thrombus) 12/2010 - 03/2003
3	Stroke (Strokes) 01/2008 - 03/2003
3	Liver Diseases (Liver Disease) 12/2005 - 08/2004
3	Esophageal and Gastric Varices (Esophageal Varices) 11/2003 - 07/2002
3	Varicose Veins (Varicose Vein) 11/2003 - 07/2002
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 04/2016
2	Pulmonary Arterial Hypertension 01/2013 - 02/2006
2	Disorders of Excessive Somnolence (Hypersomnia) 08/2011 - 08/2003
2	Shock 01/2009 - 03/2005
2	Hepatitis C 12/2006 - 04/2005
2	Autoimmune Diseases (Autoimmune Disease) 10/2005 - 09/2002
2	Virus Diseases (Viral Diseases) 10/2005 - 10/2005
2	Necrosis 10/2005 - 02/2002
2	Hypertension (High Blood Pressure) 10/2005 - 03/2003
2	Hemangioma (Angioma) 10/2005 - 02/2003
2	Disseminated Intravascular Coagulation 01/2005 - 11/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2003 - 07/2002
2	Abscess 11/2002 - 04/2002
2	Liver Abscess 11/2002 - 04/2002
1	Dehydration (Water Stress) 01/2024
1	Tardive Dyskinesia 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Cardiac Tamponade 11/2018
1	Myoclonus (Nocturnal Myoclonus) 01/2018
1	Gaucher Disease (Gaucher's Disease) 01/2018
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2018

Drug/Important Bio-Agent (IBA)

7	InterferonsIBA 12/2005 - 08/2002
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005 - 01/2002
5	rho-Associated KinasesIBA 01/2013 - 03/2003
5	NF-kappa B (NF-kB)IBA 10/2005 - 09/2002
5	SHU 508 (Levovist)IBA 10/2005 - 07/2002
5	LigandsIBA 10/2005 - 05/2002
5	Contrast MediaIBA 10/2005 - 07/2002
4	TNF-Related Apoptosis-Inducing LigandIBA 08/2006 - 05/2002
4	Ethanol (Ethyl Alcohol)IBA 11/2003 - 02/2002
3	SteroidsIBA 10/2017 - 08/2011
3	Death Domain ReceptorsIBA 08/2006 - 07/2003
3	Hepatitis B e AntigensIBA 11/2005 - 08/2002
3	AntibodiesIBA 10/2005 - 08/2004
3	Angiotensin Receptor AntagonistsIBA 12/2004 - 04/2003
3	PPAR gammaIBA 12/2003 - 01/2002
3	Tumor Biomarkers (Tumor Markers)IBA 11/2003 - 03/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2003 - 03/2002
2	Transcription Factors (Transcription Factor)IBA 01/2024 - 03/2006
2	Hormones (Hormone)IBA 10/2017 - 08/2008
2	OrexinsIBA 08/2011 - 08/2003
2	Caspase 8 (Caspase-8)IBA 08/2006 - 07/2003
2	Caspase InhibitorsIBA 03/2006 - 01/2002
2	X-Linked Inhibitor of Apoptosis ProteinIBA 11/2005 - 08/2004
2	SurvivinIBA 11/2005 - 09/2002
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 10/2005 - 08/2004
2	fibrin fragment D (D-dimer)IBA 08/2005 - 01/2005
2	FibrinIBA 08/2005 - 01/2005
2	Interleukin-18 (Interleukin 18)IBA 05/2005 - 03/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2005 - 03/2003
2	CytokinesIBA 05/2005 - 09/2002
2	Fluorouracil (Carac)FDA LinkGeneric 03/2005 - 03/2003
2	Cisplatin (Platino)FDA LinkGeneric 03/2005 - 03/2003
2	AntigensIBA 01/2005 - 01/2005
2	Dacarbazine (DIC)FDA LinkGeneric 01/2005 - 11/2002
2	Messenger RNA (mRNA)IBA 01/2005 - 01/2005
2	CamptothecinIBA 01/2005 - 09/2002
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2004 - 04/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2004 - 04/2003
2	Prednisolone (Predate)FDA LinkGeneric 07/2004 - 08/2003
2	Epirubicin (Ellence)FDA LinkGeneric 07/2004 - 03/2003
2	Dobutamine FDA LinkGeneric 01/2004 - 01/2003
2	acarboxyprothrombin (PIVKA)IBA 10/2003 - 03/2002
2	DNA (Deoxyribonucleic Acid)IBA 09/2002 - 04/2002
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2002 - 02/2002
1	TabletsIBA 01/2021
1	blonanserinIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Glucosylceramides (Glucocerebrosides)IBA 01/2018

Therapy/Procedure

20	Therapeutics 08/2011 - 02/2002
4	Catheters 01/2009 - 02/2002
3	Vena Cava Filters (Inferior Vena Cava Filter) 11/2018 - 12/2002
3	Radiofrequency Ablation 04/2005 - 12/2002
3	Drug Therapy (Chemotherapy) 03/2005 - 03/2003
3	Sclerotherapy 09/2003 - 07/2002
2	Percutaneous Coronary Intervention 09/2006 - 01/2003
2	Thrombolytic Therapy 03/2005 - 03/2005
2	Catheter Ablation 01/2005 - 02/2002
1	Enzyme Replacement Therapy 01/2018